Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Paradigm
AddedFeb 13, 2024
UpdatedJun 18, 2026
Paradigm

Paradigm

Series A

Paradigm: Revolutionizing clinical research with an efficient platform for equitable patient trial access.

HQ
New York City, NY, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Paradigm was founded with the mission to revolutionize the clinical research ecosystem by creating a platform that ensures equitable access to clinical trials for all patients. The company's vision focuses on improving trial efficiency and reducing barriers for healthcare providers, thereby facilitating broader participation in clinical research. Paradigm offers a comprehensive clinical research platform designed to streamline the trial process, making it more accessible and efficient for both patients and providers.

Notable affiliates of Paradigm include industry leaders such as Kent Thoelke, Jonathan Hirsch, and Jay Trepanier, along with investors like Robert Nelsen and Hemant Taneja. The company has achieved significant milestones in enhancing patient access to clinical trials and improving the overall efficiency of the clinical research process. Paradigm's impact is evident in its contribution to making clinical trials more inclusive and efficient, thereby advancing medical research and patient care.

Paradigm - Similar Companies

Power Life Science logo

Power Life Science

withpower.com

Medable logo

Medable

medable.com

ClinOne logo

ClinOne

clinone.com

Clinical Platform logo

Clinical Platform

MedVector logo

MedVector

medvector.com

Crescendo Health logo

Crescendo Health

crescendo.health

Infiuss Health logo

Infiuss Health

infiuss.com

Faro Health logo

Faro Health

farohealth.com

FindMeCure logo

FindMeCure

findmecure.com

SubjectWell logo

SubjectWell

subjectwell.com

Carebox logo

Carebox

careboxhealth.com

Strategikon Pharma logo

Strategikon Pharma

Leal Health logo

Leal Health

leal.health

SiteBridge Research logo

SiteBridge Research

Elligo Health Research logo

Elligo Health Research

Paradigm - Quick Facts

Who are Paradigm's competitors?

Companies similar to Paradigm include Power Life Science, Medable, ClinOne and Clinical Platform.

When was Paradigm founded?

Paradigm was founded in 2021.

Where is Paradigm's headquarters located?

Paradigm's headquarters is located in New York City, NY, US.

When was Paradigm's last funding round?

Paradigm's most recent funding round was for $203M (USD) in January 2023.

How much has Paradigm raised to-date?

As of Jan 25, 2023, Paradigm has raised a total of $203M (USD).

How many employees does Paradigm have?

Paradigm has 175 employees as of Feb 4, 2024.

Paradigm - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • HealthTech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Clinical Research
Tags
  • Healthcare
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 10 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine
  • 8060Hospitals